
Girindus is a customer-driven company offering pharmaceutical clients comprehensive skills, ranging from process development, analytical method development, radiolabeling, cGMP compliant scale-up and manufacturing of active ingredients, as well as regulatory support.
We can provide oligonucleotides at scales from milligrams to kilograms for applications from pre-clinical research and toxicology studies to clinical trials and throughout the commercial life of your product.
Moreover, Girindus is the only company providing expertise in both oligonucleotide and small molecule APIs combined with the unique offering of radioactive labeling. With our sister company Peptisyntha, we can offer oligonucleotides and peptides. All this makes us a unique one-stop-shop CMO to cover all our customer's needs.
We operate commercial scale oligonucleotide production at our FDA registered and inspected site in Cincinnati, Ohio, USA, which is also home to our laboratories and pilot plant facilities.
We offer our clients a broad range of synthesis and services for the development of oligonucleotides through the early pre-clinical stages up to the commercialization of the drug substance and beyond. Our project management team and expert associates take great care in working with our clients with empathy, flexibility, responsiveness and customer intimacy.
Address
E-mail: info@girindus.com
Website: www.girindus.com
Girindus AG
Member of the Solvay Group
Hans-Böckler-Allee 20
30173 Hannover
Germany
Tel.: +49 511 857 3535
Girindus America Inc.
Member of the Solvay Group
8560 Reading Road
Cincinnati, Ohio 45215, USA
Tel.: +1 513 679 3000
Fields marked * are compulsory